Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 20

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Relief to Lupin: High court removes ban its diabetes drug Gluconorm P 30

    Meghna A Singhania23 Feb 2019 12:57 PM IST
    The high court has now ruled in favour of Lupin and quashed the apex court's decision to ban Lupin's anti-diabetic drug- Gluconorm P 30.New Delhi: In...
    Supreme Court lifts ban on Saridon, major relief to Piramal

    Supreme Court lifts ban on Saridon, major relief to Piramal

    Meghna A Singhania21 Feb 2019 6:05 PM IST
    New Delhi: In a major relief to Piramal, the Supreme Court has exempted the popular painkiller drug Saridon from the list of Fixed Dose Combinations...
    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    NPPA likely to cap retailer margins of 73 cancer and rare disease drugs: Report

    Meghna A Singhania21 Feb 2019 3:13 PM IST
    However, the move is likely to stimulate retailers to spend more as trade margins on drugs that have somehow bypassed the list and the retailers may...
    Taking steps to ensure availability of affordable medicines to common people: Gowda

    Taking steps to ensure availability of affordable medicines to common people: Gowda

    Meghna A Singhania19 Feb 2019 9:15 AM IST
    "The government has ensured that generic medicines are available across the country in over 5,000 Jan Aushadhi Kendra," he told here on the sidelines...
    NPPA fixes retail price of Emcure pharma

    NPPA fixes retail price of Emcure pharma's HIV drug

    Meghna A Singhania17 Feb 2019 9:30 AM IST
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of Emcure...
    Tamil Nadu: Cabinet approves land allocation for vaccine plant

    Tamil Nadu: Cabinet approves land allocation for vaccine plant

    Farhat Nasim16 Feb 2019 9:15 AM IST
    The project entails production of viral vaccines such as TCA anti-measles vaccine, Japanese encephalitis and anti-sera at the PII, Coonoor. Land for...
    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugs

    AYUSH ministry launches e-AUSHADHI portal for online licensing of drugs

    Meghna A Singhania15 Feb 2019 9:25 AM IST
    Speaking on the occasion, Vaidya Rajesh Kotecha, Secretary, Ministry of AYUSH, said the ministry endeavoured to come out with new initiatives and...
    80 percent hike in price of Polio Vaccine in two years: Minister informs Parliament

    80 percent hike in price of Polio Vaccine in two years: Minister informs Parliament

    Meghna A Singhania10 Feb 2019 1:38 PM IST
    New Delhi: A sharp rise in the price of the Polio Vaccine has been witnessed in a period of just two years, as has been revealed by the response given...
    Issue of Relabelling of old and expired medicines raised in Parliament, MOS Health Responds

    Issue of Relabelling of old and expired medicines raised in Parliament, MOS Health Responds

    Meghna A Singhania7 Feb 2019 3:50 PM IST
    Giving a written response to the questions put forth, the minister informed that a representation regarding expired medicines being relabelled as...
    Unethical practices by companies in medical devices industry: Nadda apprises Rajya Sabha

    Unethical practices by companies in medical devices industry: Nadda apprises Rajya Sabha

    Meghna A Singhania6 Feb 2019 3:38 PM IST
    New Delhi: Shri JP Nadda, The Union Minister of Health and Family Welfare recently answered many grave questions raised in the Rajya Sabha pointedly...
    Akum Drugs, Lupin, DRL bags India Pharma Award 2019; Details

    Akum Drugs, Lupin, DRL bags India Pharma Award 2019; Details

    Farhat Nasim6 Feb 2019 9:40 AM IST
    The awards will be conferred during the India Pharma 2019 and India Medical Device 2019 to be held on 18th February 2019.New Delhi: Various...
    New Pharma Policy approved in Haryana, to generate 25000 new jobs

    New Pharma Policy approved in Haryana, to generate 25000 new jobs

    Meghna A Singhania5 Feb 2019 10:53 AM IST
    Haryana: Aiming to attract investment in the pharmaceutical sector to the tune of Rs 2,000 crore and to generate 25,000 new jobs, the Haryana Cabinet...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    KKRs Envision Healthcare hires bank to explore debt restructuring: Report

    KKR's Envision Healthcare hires bank to explore debt restructuring: Report

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok